This paper is in the following e-collection/theme issue:

Letters (85) JMIR Theme Issue: COVID-19 Special Issue (2452) Digital Science, Open Science (79) Epublishing and Open Access (86) Outbreak and Pandemic Preparedness and Management (1727) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1517)

Published on in Vol 23, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27937, first published .
COVID-19 as a “Force Majeure” for Non–COVID-19 Clinical and Translational Research. Comment on “Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study”

COVID-19 as a “Force Majeure” for Non–COVID-19 Clinical and Translational Research. Comment on “Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study”

COVID-19 as a “Force Majeure” for Non–COVID-19 Clinical and Translational Research. Comment on “Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study”

Authors of this article:

Petar Milovanovic1 Author Orcid Image ;   Igor Dumic2 Author Orcid Image
Article Authors Cited by (3) Tweetations (1) Metrics

Journals

  1. Älgå A, Eriksson O, Nordberg M. Authors' Reply to: COVID-19 as a “Force Majeure” for Non–COVID-19 Clinical and Translational Research. Comment on “Analysis of Scientific Publications During the Early Phase of the COVID-19 Pandemic: Topic Modeling Study”. Journal of Medical Internet Research 2021;23(5):e29156 View
  2. Becker A. Effects of the coronavirus 2019 pandemic on medical publishing: The sacrifice of quality for quantity?. Learned Publishing 2024;37(4) View

Books/Policy Documents

  1. Diaconu D. Force Majeure in the Hydropower Industry. View